In accordance with Article 13 of Law No. 104-12 on freedom of prices and competition and Article 10 of Decree No. 2-14-652 issued for its implementation, as amended and supplemented, the Competition Council makes available to the public the ‘operation summary’ below, containing the information provided by the parties.<\/p>\n
This information has been prepared by the notifying parties, who are solely responsible. Any inaccurate or distorted information contained therein does not in any way prejudge the Competition Council’s position on the proposed operation.<\/p>\n
The publication of this press release does not attest to the completeness of the file provided for in Article 9 of Decree No. 2-14-652 issued for the implementation of Law No. 104-12 on freedom of prices and competition as amended and supplemented.<\/p>\n
Names of the companies and groups concerned:<\/strong><\/p>\n Nature of the operation:<\/strong><\/p>\n Economic sector concerned:<\/strong><\/p>\n Deadline for interested third parties to submit their observations:<\/strong><\/p>\n NON-CONFIDENTIAL SUMMARY OF THE OPERATION PROVIDED BY THE PARTIES<\/strong><\/p>\n The Competition Council received notification of an economic concentration operation consisting of the joint control acquisition by the investment fund ‘SPE PEF III LP’ of the company ‘Groupe Sant\u00e9 Tilila SA’ alongside the historical shareholders through the acquisition of 40% of its share capital and related voting rights.<\/p>\n ‘SPE PEF III LP’ is a limited partnership company under Mauritian law with its registered office at C\/o Axis Fiduciary Ltd, 2nd Floor, The Axis, 26 Cybercity, Ebene, 72201, Mauritius, registered with the Mauritian Companies Register under number L255 GBL. It is a private equity fund focusing on Africa and targeting high-growth SMEs active in the education, health, industry, and business services sectors.<\/p>\n ‘Groupe Sant\u00e9 Tilila SA’ is a Moroccan joint-stock company, with its registered office in Agadir, in the process of registration with the Agadir Trade Register. It is a holding company whose sole subsidiary is ‘Clinique Tilila SARL’.<\/p>\n ‘Clinique Tilila SARL’ is a Moroccan limited liability company with its registered office at Quartier du Prince H\u00e9ritier Rue Oujjaj CPH 1 Agadir (Morocco), registered with the Agadir Trade Register under number 4343. It operates a multidisciplinary clinic offering various services including oncology services (chemotherapy and radiotherapy) and radiology.<\/p>\n <\/p>\n Done in Rabat on September 1, 2025<\/p>\n","protected":false},"excerpt":{"rendered":" In accordance with Article 13 of Law No. 104-12 on freedom of prices and competition and Article 10 of Decree No. 2-14-652 issued for its implementation, as amended and supplemented, the Competition Council makes available to the public the ‘operation summary’ below, containing the information provided by the parties. This information has been prepared by the notifying parties, who are solely responsible. Any inaccurate or distorted information contained therein does not in any way prejudge the Competition Council’s position on the proposed operation. The publication of this press release does not attest to the completeness of the file provided for in Article 9 of Decree No. 2-14-652 issued for the implementation of Law No. 104-12 on freedom of prices and competition as amended and supplemented. Names of the companies and groups concerned: The acquirer: ‘SPE PEF III LP’; The historical shareholders: Dr. Mostafa Attaf and Dr. Sabah Ben Abdelkrim El Filali; The target: ‘Groupe Sant\u00e9 Tilila SA’. Nature of the operation: Joint control acquisition. Economic sector concerned: Sector of the provision of diagnostics and hospital care within private clinics and similar establishments Deadline for interested third parties to submit their observations: 10 days from the date of publication of this press release, i.e., September 11, 2025. NON-CONFIDENTIAL SUMMARY OF THE OPERATION PROVIDED BY THE PARTIES The Competition Council received notification of an economic concentration operation consisting of the joint control acquisition by the investment fund ‘SPE PEF III LP’ of the company ‘Groupe Sant\u00e9 Tilila SA’ alongside the historical shareholders through the acquisition of 40% of its share capital and related voting rights. ‘SPE PEF III LP’ is a limited partnership company under Mauritian law with its registered office at C\/o Axis Fiduciary Ltd, 2nd Floor, The Axis, 26 Cybercity, Ebene, 72201, Mauritius, registered with the Mauritian Companies Register under number L255 GBL. It is a private equity fund focusing on Africa and targeting high-growth SMEs active in the education, health, industry, and business services sectors. ‘Groupe Sant\u00e9 Tilila SA’ is a Moroccan joint-stock company, with its registered office in Agadir, in the process of registration with the Agadir Trade Register. It is a holding company whose sole subsidiary is ‘Clinique Tilila SARL’. ‘Clinique Tilila SARL’ is a Moroccan limited liability company with its registered office at Quartier du Prince H\u00e9ritier Rue Oujjaj CPH 1 Agadir (Morocco), registered with the Agadir Trade Register under number 4343. It operates a multidisciplinary clinic offering various services including oncology services (chemotherapy and radiotherapy) and radiology. Done in Rabat on September 1, 2025<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[352],"tags":[],"class_list":["post-39184","post","type-post","status-publish","format-standard","hentry","category-press-releases"],"acf":[],"yoast_head":"\n\n
\n
\n
\n